Sex hormone binding globulin (SHBG) as a predictor of liver fibrosis in subjects with nonalcoholic fatty liver disease (NAFLD)

[1]  S. Pouwels,et al.  Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss , 2022, BMC Endocrine Disorders.

[2]  Y. Liao,et al.  Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis , 2022, Therapeutic advances in endocrinology and metabolism.

[3]  R. Donnelly,et al.  Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome , 2020, International journal of molecular sciences.

[4]  M. Hill,et al.  Estradiol, obesity and hypogonadism. , 2020, Physiological research.

[5]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[6]  L. Hodson,et al.  Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management. , 2019, Endocrine reviews.

[7]  T. Yanase,et al.  High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men. , 2019, Endocrine journal.

[8]  Kusheng Wu,et al.  Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone–binding globulin, and hypertension , 2019, Medicine.

[9]  C. Mantzoros,et al.  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. , 2019, Metabolism: clinical and experimental.

[10]  Xu Wang,et al.  Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults , 2018, Nutrition & Metabolism.

[11]  L. Bolondi,et al.  Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis , 2018, World journal of gastroenterology.

[12]  Michael Charlton,et al.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.

[13]  Yun Hu,et al.  Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients , 2017, Scientific Reports.

[14]  R. Simó,et al.  Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development , 2017, Endocrinology.

[15]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[16]  R. Niknam,et al.  The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study , 2016, Middle East journal of digestive diseases.

[17]  E. Guallar,et al.  Metabolically Healthy Obesity and Development of Chronic Kidney Disease , 2016, Annals of Internal Medicine.

[18]  Yingli Lu,et al.  Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women , 2016, Medicine.

[19]  Sujoy Ghosh,et al.  Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes , 2015, Indian journal of endocrinology and metabolism.

[20]  B. Balkau,et al.  Role of sex steroids, intrahepatic fat and liver enzymes in the association between SHBG and metabolic features , 2013, Clinical endocrinology.

[21]  M. Flechtner-Mors,et al.  Associations of Fatty Liver Disease and Other Factors Affecting Serum SHBG Concentrations: A Population Based Study on 1657 Subjects , 2013, Hormone and Metabolic Research.

[22]  L. Råstam,et al.  Low sex hormone-binding globulin is associated with hypertension: a cross-sectional study in a Swedish population , 2013, BMC Cardiovascular Disorders.

[23]  L. N. Valenti,et al.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.

[24]  Zhou-wen Chen,et al.  Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease , 2008, Journal of Zhejiang University SCIENCE B.

[25]  S. Bandinelli,et al.  Sex hormone binding globulin levels across the adult lifespan in women — The role of body mass index and fasting insulin , 2008, Journal of endocrinological investigation.

[26]  K. Eguchi,et al.  Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[27]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[28]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[29]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[30]  C. Nolasco-Hipólito,et al.  Liver enzymes in patients diagnosed with non-alcoholic fatty liver disease (NAFLD) in Veracruz: a comparative analysis with the literature , 2017 .

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..